Hospitals deal with record drug shortage
Photo credit: Newsday/Karen Wiles Stabile | The Doxil shortage is due to "a manufacturing problem related to capacity," said Lisa Vaga, spokeswoman for Janssen Pharmaceuticals, the biotech firm that makes the ovarian cancer drug. The drug is one of many in short supply across the United States. (Aug. 24, 2011)
A record number of drugs are in short supply nationwide -- a crisis that is being felt by Long Island hospitals as they scramble to find medicines for patients facing serious medical conditions.
The bulk of the shortage involves generic, injectable drugs used in hospitals and clinics. More than 180 medications -- from those treating cancer and childhood leukemia to surgical anesthetics and...